HMG-CoA Reductase Inhibitors:
HMG-CoA reductase inhibitors (statins) are established drugs for the treatment of hypercholesterolemia. Furthermore, they induce regression of vascular atherosclerosis as well as reduction of cardiovascular-related morbidity and death in patients with and without coronary artery disease. This book d...
Gespeichert in:
Weitere Verfasser: | , |
---|---|
Format: | Elektronisch E-Book |
Sprache: | English |
Veröffentlicht: |
Basel
Birkhäuser Basel
2002
|
Schriftenreihe: | Milestones in Drug Therapy
|
Schlagworte: | |
Online-Zugang: | UBR01 Volltext |
Zusammenfassung: | HMG-CoA reductase inhibitors (statins) are established drugs for the treatment of hypercholesterolemia. Furthermore, they induce regression of vascular atherosclerosis as well as reduction of cardiovascular-related morbidity and death in patients with and without coronary artery disease. This book deals with statins which have substantially altered the approach to therapy of atherosclerosis and its sequelae. Emphasis is placed on the scientific background to the discoveries and the development of the therapy, including an overview of the current state of knowledge of the drugs. Clinical data are reviewed extensively. This book not only provides the reader with valuable information but also stimulates further research into the pathogenesis of atherosclerosis and the mechanisms behind the action of effective statins. It sets the stage for creative thinking among scientists of many disciplines for the accomplishment of our ultimate goals in treating atherosclerosis and its sequelae. This topical volume.. |
Beschreibung: | 1 Online-Ressource (X, 151 p) |
ISBN: | 9783034881357 |
DOI: | 10.1007/978-3-0348-8135-7 |
Internformat
MARC
LEADER | 00000nmm a2200000zc 4500 | ||
---|---|---|---|
001 | BV046149109 | ||
003 | DE-604 | ||
005 | 00000000000000.0 | ||
007 | cr|uuu---uuuuu | ||
008 | 190906s2002 |||| o||u| ||||||eng d | ||
020 | |a 9783034881357 |9 978-3-0348-8135-7 | ||
024 | 7 | |a 10.1007/978-3-0348-8135-7 |2 doi | |
035 | |a (ZDB-2-SBL)978-3-0348-8135-7 | ||
035 | |a (OCoLC)1119018022 | ||
035 | |a (DE-599)BVBBV046149109 | ||
040 | |a DE-604 |b ger |e aacr | ||
041 | 0 | |a eng | |
049 | |a DE-355 | ||
082 | 0 | |a 615.1 |2 23 | |
084 | |a YC 7415 |0 (DE-625)153255:12921 |2 rvk | ||
245 | 1 | 0 | |a HMG-CoA Reductase Inhibitors |c edited by Gerd Schmitz, Michael Torzewski |
264 | 1 | |a Basel |b Birkhäuser Basel |c 2002 | |
300 | |a 1 Online-Ressource (X, 151 p) | ||
336 | |b txt |2 rdacontent | ||
337 | |b c |2 rdamedia | ||
338 | |b cr |2 rdacarrier | ||
490 | 0 | |a Milestones in Drug Therapy | |
520 | |a HMG-CoA reductase inhibitors (statins) are established drugs for the treatment of hypercholesterolemia. Furthermore, they induce regression of vascular atherosclerosis as well as reduction of cardiovascular-related morbidity and death in patients with and without coronary artery disease. This book deals with statins which have substantially altered the approach to therapy of atherosclerosis and its sequelae. Emphasis is placed on the scientific background to the discoveries and the development of the therapy, including an overview of the current state of knowledge of the drugs. Clinical data are reviewed extensively. This book not only provides the reader with valuable information but also stimulates further research into the pathogenesis of atherosclerosis and the mechanisms behind the action of effective statins. It sets the stage for creative thinking among scientists of many disciplines for the accomplishment of our ultimate goals in treating atherosclerosis and its sequelae. This topical volume.. | ||
650 | 4 | |a Pharmacy | |
650 | 4 | |a Pharmacy | |
650 | 0 | 7 | |a Statine |0 (DE-588)4583019-8 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Inhibitor |0 (DE-588)4027007-5 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Hydroxymethylglutaryl-CoA-Reductase |0 (DE-588)4161000-3 |2 gnd |9 rswk-swf |
655 | 7 | |0 (DE-588)4143413-4 |a Aufsatzsammlung |2 gnd-content | |
689 | 0 | 0 | |a Hydroxymethylglutaryl-CoA-Reductase |0 (DE-588)4161000-3 |D s |
689 | 0 | 1 | |a Inhibitor |0 (DE-588)4027007-5 |D s |
689 | 0 | |5 DE-604 | |
689 | 1 | 0 | |a Statine |0 (DE-588)4583019-8 |D s |
689 | 1 | |5 DE-604 | |
700 | 1 | |a Schmitz, Gerd |4 edt | |
700 | 1 | |a Torzewski, Michael |4 edt | |
776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9783034894517 |
776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9783764363079 |
776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9783034881364 |
856 | 4 | 0 | |u https://doi.org/10.1007/978-3-0348-8135-7 |x Verlag |z URL des Erstveröffentlichers |3 Volltext |
912 | |a ZDB-2-SBL | ||
940 | 1 | |q ZDB-2-SBL_2000/2004 | |
999 | |a oai:aleph.bib-bvb.de:BVB01-031529286 | ||
966 | e | |u https://doi.org/10.1007/978-3-0348-8135-7 |l UBR01 |p ZDB-2-SBL |q ZDB-2-SBL_2000/2004 |x Verlag |3 Volltext |
Datensatz im Suchindex
_version_ | 1804180490225188864 |
---|---|
any_adam_object | |
author2 | Schmitz, Gerd Torzewski, Michael |
author2_role | edt edt |
author2_variant | g s gs m t mt |
author_facet | Schmitz, Gerd Torzewski, Michael |
building | Verbundindex |
bvnumber | BV046149109 |
classification_rvk | YC 7415 |
collection | ZDB-2-SBL |
ctrlnum | (ZDB-2-SBL)978-3-0348-8135-7 (OCoLC)1119018022 (DE-599)BVBBV046149109 |
dewey-full | 615.1 |
dewey-hundreds | 600 - Technology (Applied sciences) |
dewey-ones | 615 - Pharmacology and therapeutics |
dewey-raw | 615.1 |
dewey-search | 615.1 |
dewey-sort | 3615.1 |
dewey-tens | 610 - Medicine and health |
discipline | Medizin |
doi_str_mv | 10.1007/978-3-0348-8135-7 |
format | Electronic eBook |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03033nmm a2200553zc 4500</leader><controlfield tag="001">BV046149109</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">190906s2002 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9783034881357</subfield><subfield code="9">978-3-0348-8135-7</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/978-3-0348-8135-7</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-2-SBL)978-3-0348-8135-7</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1119018022</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV046149109</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">615.1</subfield><subfield code="2">23</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">YC 7415</subfield><subfield code="0">(DE-625)153255:12921</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">HMG-CoA Reductase Inhibitors</subfield><subfield code="c">edited by Gerd Schmitz, Michael Torzewski</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Basel</subfield><subfield code="b">Birkhäuser Basel</subfield><subfield code="c">2002</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (X, 151 p)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Milestones in Drug Therapy</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">HMG-CoA reductase inhibitors (statins) are established drugs for the treatment of hypercholesterolemia. Furthermore, they induce regression of vascular atherosclerosis as well as reduction of cardiovascular-related morbidity and death in patients with and without coronary artery disease. This book deals with statins which have substantially altered the approach to therapy of atherosclerosis and its sequelae. Emphasis is placed on the scientific background to the discoveries and the development of the therapy, including an overview of the current state of knowledge of the drugs. Clinical data are reviewed extensively. This book not only provides the reader with valuable information but also stimulates further research into the pathogenesis of atherosclerosis and the mechanisms behind the action of effective statins. It sets the stage for creative thinking among scientists of many disciplines for the accomplishment of our ultimate goals in treating atherosclerosis and its sequelae. This topical volume..</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmacy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmacy</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Statine</subfield><subfield code="0">(DE-588)4583019-8</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Inhibitor</subfield><subfield code="0">(DE-588)4027007-5</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Hydroxymethylglutaryl-CoA-Reductase</subfield><subfield code="0">(DE-588)4161000-3</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)4143413-4</subfield><subfield code="a">Aufsatzsammlung</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Hydroxymethylglutaryl-CoA-Reductase</subfield><subfield code="0">(DE-588)4161000-3</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Inhibitor</subfield><subfield code="0">(DE-588)4027007-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Statine</subfield><subfield code="0">(DE-588)4583019-8</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Schmitz, Gerd</subfield><subfield code="4">edt</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Torzewski, Michael</subfield><subfield code="4">edt</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9783034894517</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9783764363079</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9783034881364</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1007/978-3-0348-8135-7</subfield><subfield code="x">Verlag</subfield><subfield code="z">URL des Erstveröffentlichers</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-2-SBL</subfield></datafield><datafield tag="940" ind1="1" ind2=" "><subfield code="q">ZDB-2-SBL_2000/2004</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-031529286</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1007/978-3-0348-8135-7</subfield><subfield code="l">UBR01</subfield><subfield code="p">ZDB-2-SBL</subfield><subfield code="q">ZDB-2-SBL_2000/2004</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
genre | (DE-588)4143413-4 Aufsatzsammlung gnd-content |
genre_facet | Aufsatzsammlung |
id | DE-604.BV046149109 |
illustrated | Not Illustrated |
indexdate | 2024-07-10T08:36:35Z |
institution | BVB |
isbn | 9783034881357 |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-031529286 |
oclc_num | 1119018022 |
open_access_boolean | |
owner | DE-355 DE-BY-UBR |
owner_facet | DE-355 DE-BY-UBR |
physical | 1 Online-Ressource (X, 151 p) |
psigel | ZDB-2-SBL ZDB-2-SBL_2000/2004 ZDB-2-SBL ZDB-2-SBL_2000/2004 |
publishDate | 2002 |
publishDateSearch | 2002 |
publishDateSort | 2002 |
publisher | Birkhäuser Basel |
record_format | marc |
series2 | Milestones in Drug Therapy |
spelling | HMG-CoA Reductase Inhibitors edited by Gerd Schmitz, Michael Torzewski Basel Birkhäuser Basel 2002 1 Online-Ressource (X, 151 p) txt rdacontent c rdamedia cr rdacarrier Milestones in Drug Therapy HMG-CoA reductase inhibitors (statins) are established drugs for the treatment of hypercholesterolemia. Furthermore, they induce regression of vascular atherosclerosis as well as reduction of cardiovascular-related morbidity and death in patients with and without coronary artery disease. This book deals with statins which have substantially altered the approach to therapy of atherosclerosis and its sequelae. Emphasis is placed on the scientific background to the discoveries and the development of the therapy, including an overview of the current state of knowledge of the drugs. Clinical data are reviewed extensively. This book not only provides the reader with valuable information but also stimulates further research into the pathogenesis of atherosclerosis and the mechanisms behind the action of effective statins. It sets the stage for creative thinking among scientists of many disciplines for the accomplishment of our ultimate goals in treating atherosclerosis and its sequelae. This topical volume.. Pharmacy Statine (DE-588)4583019-8 gnd rswk-swf Inhibitor (DE-588)4027007-5 gnd rswk-swf Hydroxymethylglutaryl-CoA-Reductase (DE-588)4161000-3 gnd rswk-swf (DE-588)4143413-4 Aufsatzsammlung gnd-content Hydroxymethylglutaryl-CoA-Reductase (DE-588)4161000-3 s Inhibitor (DE-588)4027007-5 s DE-604 Statine (DE-588)4583019-8 s Schmitz, Gerd edt Torzewski, Michael edt Erscheint auch als Druck-Ausgabe 9783034894517 Erscheint auch als Druck-Ausgabe 9783764363079 Erscheint auch als Druck-Ausgabe 9783034881364 https://doi.org/10.1007/978-3-0348-8135-7 Verlag URL des Erstveröffentlichers Volltext |
spellingShingle | HMG-CoA Reductase Inhibitors Pharmacy Statine (DE-588)4583019-8 gnd Inhibitor (DE-588)4027007-5 gnd Hydroxymethylglutaryl-CoA-Reductase (DE-588)4161000-3 gnd |
subject_GND | (DE-588)4583019-8 (DE-588)4027007-5 (DE-588)4161000-3 (DE-588)4143413-4 |
title | HMG-CoA Reductase Inhibitors |
title_auth | HMG-CoA Reductase Inhibitors |
title_exact_search | HMG-CoA Reductase Inhibitors |
title_full | HMG-CoA Reductase Inhibitors edited by Gerd Schmitz, Michael Torzewski |
title_fullStr | HMG-CoA Reductase Inhibitors edited by Gerd Schmitz, Michael Torzewski |
title_full_unstemmed | HMG-CoA Reductase Inhibitors edited by Gerd Schmitz, Michael Torzewski |
title_short | HMG-CoA Reductase Inhibitors |
title_sort | hmg coa reductase inhibitors |
topic | Pharmacy Statine (DE-588)4583019-8 gnd Inhibitor (DE-588)4027007-5 gnd Hydroxymethylglutaryl-CoA-Reductase (DE-588)4161000-3 gnd |
topic_facet | Pharmacy Statine Inhibitor Hydroxymethylglutaryl-CoA-Reductase Aufsatzsammlung |
url | https://doi.org/10.1007/978-3-0348-8135-7 |
work_keys_str_mv | AT schmitzgerd hmgcoareductaseinhibitors AT torzewskimichael hmgcoareductaseinhibitors |